• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过结核分枝杆菌过氧化氢酶-过氧化物酶KatG中的关键突变模拟对异烟肼耐药性的结构起源

Modeling the structural origins of drug resistance to isoniazid via key mutations in Mycobacterium tuberculosis catalase-peroxidase, KatG.

作者信息

Marney Matthew W, Metzger Robert P, Hecht David, Valafar Faramarz

机构信息

Department of Chemistry and Biochemistry, San Diego State University, San Diego, CA 92182-1030, USA.

Department of Chemistry and Biochemistry, San Diego State University, San Diego, CA 92182-1030, USA; Department of Chemistry, Southwestern College, Chula Vista, CA 91910, USA.

出版信息

Tuberculosis (Edinb). 2018 Jan;108:155-162. doi: 10.1016/j.tube.2017.11.007. Epub 2017 Nov 22.

DOI:10.1016/j.tube.2017.11.007
PMID:29523317
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7330162/
Abstract

WHO reported 10.4 million new tuberculosis (TB) cases and 1.8 million deaths in 2015, making M. tuberculosis the most successful human pathogen with highest mortality among infectious diseases [1,2]. Drug-resistant TB is a major threat to global TB control [2,3]. Recently Torres et al. [4] identified 14 novel substitutions in M. tuberculosis-KatG (the enzyme associated with resistance to isoniazid-an important first-line anti-TB drug) and demonstrated that 12 of the 14 can cause INH-resistance in M. smegmatis. This study presents an in silico structure-based analysis of these 14 amino acid substitutions using homology models and x-ray crystal structures (when available) in M. tuberculosis. Our models demonstrate that several of these mutations cluster around three openings in the KatG tertiary structure which appear to initiate channels to the heme group at the catalytic center of the enzyme. We studied the effects of these mutations on the tertiary structure of KatG, focusing on conformational changes in the three channels in the protein structure. Our results suggest that the 14 novel mutations sufficiently restrict one or more of these access channels, thus potentially preventing INH from reaching the catalytic heme. These observations provide valuable insights into the structure-based origins of INH resistance and provide testable hypotheses for future experimental studies.

摘要

世界卫生组织报告称,2015年有1040万新发结核病病例,180万人死亡,这使得结核分枝杆菌成为最成功的人类病原体,在传染病中死亡率最高[1,2]。耐多药结核病是全球结核病控制的主要威胁[2,3]。最近,托雷斯等人[4]在结核分枝杆菌KatG(与对异烟肼——一种重要的一线抗结核药物的耐药性相关的酶)中鉴定出14个新的替换位点,并证明这14个位点中的12个可导致耻垢分枝杆菌对异烟肼产生耐药性。本研究利用结核分枝杆菌的同源模型和X射线晶体结构(如有),对这14个氨基酸替换进行了基于计算机模拟结构的分析。我们的模型表明,其中几个突变聚集在KatG三级结构的三个开口周围,这些开口似乎通向该酶催化中心的血红素基团。我们研究了这些突变对KatG三级结构的影响,重点关注蛋白质结构中三个通道的构象变化。我们的结果表明,这14个新突变充分限制了这些通道中的一个或多个,从而可能阻止异烟肼到达催化血红素。这些观察结果为异烟肼耐药性的基于结构的起源提供了有价值的见解,并为未来的实验研究提供了可检验的假设。

相似文献

1
Modeling the structural origins of drug resistance to isoniazid via key mutations in Mycobacterium tuberculosis catalase-peroxidase, KatG.通过结核分枝杆菌过氧化氢酶-过氧化物酶KatG中的关键突变模拟对异烟肼耐药性的结构起源
Tuberculosis (Edinb). 2018 Jan;108:155-162. doi: 10.1016/j.tube.2017.11.007. Epub 2017 Nov 22.
2
Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.结核分枝杆菌中异烟肼耐药相关的过氧化氢酶-过氧化物酶(KatG)临床突变体与异烟肼衍生物相互作用分析。
J Glob Antimicrob Resist. 2017 Dec;11:57-67. doi: 10.1016/j.jgar.2017.06.014. Epub 2017 Jul 23.
3
Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.结核分枝杆菌临床分离株中katG的突变:对过氧化氢酶-过氧化物酶激活异烟肼的影响。
Ukr Biochem J. 2016 Sep-Oct;88(5):71-81. doi: 10.15407/ubj88.05.071.
4
Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.结核分枝杆菌 KatG 中异烟肼耐药相关突变:过氧化氢酶、过氧化物酶和 INH-NADH 加合物的形成活性。
Protein Sci. 2010 Mar;19(3):458-74. doi: 10.1002/pro.324.
5
Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.来自结核分枝杆菌低水平和高水平异烟肼耐药临床分离株的新型KatG突变体酶活性的比较研究
Tuberculosis (Edinb). 2016 Sep;100:15-24. doi: 10.1016/j.tube.2016.06.002. Epub 2016 Jun 16.
6
Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).结核分枝杆菌中的抗生素耐药性:过氧化物酶中间旁路导致结核分枝杆菌过氧化氢酶-过氧化物酶(KatG)的S315G突变体对异烟肼的活化能力较差。
J Biol Chem. 2009 Jun 12;284(24):16146-16155. doi: 10.1074/jbc.M109.005546. Epub 2009 Apr 9.
7
Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis.过氧化氢酶-过氧化物酶(KatG)突变在介导结核分枝杆菌临床分离株异烟肼耐药中的意义。
J Glob Antimicrob Resist. 2018 Dec;15:111-120. doi: 10.1016/j.jgar.2018.07.001. Epub 2018 Jul 7.
8
Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations.来自耐异烟肼结核分枝杆菌临床分离株的过氧化氢酶-过氧化物酶KatG突变:分子动力学模拟的见解
J Mol Model. 2017 Apr;23(4):121. doi: 10.1007/s00894-017-3290-3. Epub 2017 Mar 16.
9
Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.katG 表达下调与结核分枝杆菌异烟肼耐药相关。
Mol Microbiol. 2011 Mar;79(6):1615-28. doi: 10.1111/j.1365-2958.2011.07547.x. Epub 2011 Feb 10.
10
Molecular Analysis of Encoding Catalase-Peroxidase from Clinical Isolate of Isoniazid-Resistant Mycobacterium tuberculosis.耐异烟肼结核分枝杆菌临床分离株编码过氧化氢酶-过氧化物酶的分子分析
J Med Life. 2018 Apr-Jun;11(2):160-167.

引用本文的文献

1
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis.结核分枝杆菌中贝达喹啉和氯法齐明耐药性:体外和计算机模拟数据分析。
Lancet Microbe. 2023 May;4(5):e358-e368. doi: 10.1016/S2666-5247(23)00002-2. Epub 2023 Mar 29.
2
Deciphering Isoniazid Drug Resistance Mechanisms on Dimeric KatG via Post-molecular Dynamics Analyses Including Combined Dynamic Residue Network Metrics.通过包括组合动态残基网络指标在内的分子动力学后分析来解析二聚体KatG上的异烟肼耐药机制。
ACS Omega. 2022 Apr 7;7(15):13313-13332. doi: 10.1021/acsomega.2c01036. eCollection 2022 Apr 19.
3
Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis.使用冷冻电镜理解结核分枝杆菌过氧化氢酶-过氧化物酶(KatG)的抗分枝杆菌耐药性。
Structure. 2021 Aug 5;29(8):899-912.e4. doi: 10.1016/j.str.2020.12.008. Epub 2021 Jan 13.
4
, Basonym , Expresses Morphological Phenotypes Much More Similar to Than in Quantitative Structome Analysis and CryoTEM Examination.在定量结构组分析和冷冻透射电子显微镜检查中,基原异名比……更能表达与……形态学表型更为相似的特征。(原文表述不太完整准确,翻译可能会存在一定局限性)
Front Microbiol. 2018 Sep 11;9:1992. doi: 10.3389/fmicb.2018.01992. eCollection 2018.

本文引用的文献

1
Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations.来自耐异烟肼结核分枝杆菌临床分离株的过氧化氢酶-过氧化物酶KatG突变:分子动力学模拟的见解
J Mol Model. 2017 Apr;23(4):121. doi: 10.1007/s00894-017-3290-3. Epub 2017 Mar 16.
2
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.潜伏性结核感染的全球负担:使用数学模型的重新估计
PLoS Med. 2016 Oct 25;13(10):e1002152. doi: 10.1371/journal.pmed.1002152. eCollection 2016 Oct.
3
New Antituberculosis Drugs: From Clinical Trial to Programmatic Use.新型抗结核药物:从临床试验到项目应用。
Infect Dis Rep. 2016 Jun 24;8(2):6569. doi: 10.4081/idr.2016.6569.
4
Isoniazid-resistant tuberculosis in Iran: A systematic review.伊朗耐异烟肼结核病:一项系统综述。
Tuberculosis (Edinb). 2016 May;98:104-9. doi: 10.1016/j.tube.2016.03.007. Epub 2016 Mar 26.
5
Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates.用于检测结核分枝杆菌临床分离株异烟肼耐药性的突变谱分析
J Antimicrob Chemother. 2015 Dec;70(12):3214-21. doi: 10.1093/jac/dkv253. Epub 2015 Aug 25.
6
Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.临床结核分枝杆菌分离株中导致异烟肼耐药的新型katG基因突变
Emerg Microbes Infect. 2015 Jul;4(7):e42. doi: 10.1038/emi.2015.42. Epub 2015 Jul 15.
7
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.结核分枝杆菌对异烟肼和乙硫异烟胺的耐药性:基因、突变和因果关系。
Microbiol Spectr. 2014 Aug;2(4):MGM2-0014-2013. doi: 10.1128/microbiolspec.MGM2-0014-2013.
8
The crystal structure of isoniazid-bound KatG catalase-peroxidase from Synechococcus elongatus PCC7942.来自集胞藻 PCC7942 的异烟肼结合 KatG 过氧化氢酶过氧化物酶的晶体结构。
FEBS J. 2015 Jan;282(1):54-64. doi: 10.1111/febs.13102. Epub 2014 Oct 30.
9
Reliability of Mycobacterial Growth Indicator Tube (MGIT) 960 for the detection of isoniazid resistance in a tuberculosis endemic setting.分枝杆菌生长指示管(MGIT)960在结核病流行地区检测异烟肼耐药性的可靠性
Indian J Med Res. 2014 Mar;139(3):471-3.
10
Access channel residues Ser315 and Asp137 in Mycobacterium tuberculosis catalase-peroxidase (KatG) control peroxidatic activation of the pro-drug isoniazid.结核分枝杆菌过氧化氢酶-过氧化物酶(KatG)中的活性位点残基丝氨酸 315 和天冬氨酸 137 控制异烟肼前药的过氧活化。
Chem Commun (Camb). 2013 Dec 25;49(99):11650-2. doi: 10.1039/c3cc47022a.